RIO DE JANEIRO, BRAZIL - Argentina's medicine and food regulator granted on Tuesday, December 22nd, an emergency use for the Pfizer/BioNtech vaccine in the country. These vaccines are expected to arrive in Argentina sometime between January and March.
“The product presents an acceptable benefit-risk equilibrium, which enables awarding the registration and conditional authorization for the indicated purpose” was the statement from the Medicines, Food and Medical Technological National Administration, ANMAT, a rare organizations in the Argentine bureaucracy which enjoys international recognition for its rigorous scientific expertise.
Based on this authorization and the fact that some 6,000 Argentines . . .